Understanding the diabetes- breast cancer link on hyperglycemia-hypoxia axis may give way to understanding the role of HIF1 in developing this link, which could then be employed to determine the prognostic outcome of targeting HIF1 in comorbid patients. This evidence concerns the gene HIF1A and breast cancer.